COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2

Lambertus G. Thijs; C. Erik Hack; Robert J.M. Strack Van Schijndel; Jan H. Nuijens; Gert Jan Wolbink; Anke J.M. Eerenberg-Belmer; Henry Van Der Vall; John Wagstaff

doi:https://doi.org/10.1016/S0140-6736(89)90577-1

COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2

Lambertus G. Thijs, C. Erik Hack, Robert J.M. Strack Van Schijndel, Jan H. Nuijens, Gert Jan Wolbink, Anke J.M. Eerenberg-Belmer, Henry Van Der Vall, John Wagstaff

Research output: Contribution to journal › Comment/Letter to the editor › Academic

13 Citations (Scopus)

Original language	English
Pages (from-to)	395
Number of pages	1
Journal	The Lancet
Volume	334
Issue number	8659
DOIs	https://doi.org/10.1016/S0140-6736(89)90577-1
Publication status	Published - 12 Aug 1989

Access to Document

https://doi.org/10.1016/S0140-6736(89)90577-1

Cite this

@article{ba69a5a5d0e942ab9ccded218d8b314b,

title = "COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2",

author = "Thijs, {Lambertus G.} and Hack, {C. Erik} and {Strack Van Schijndel}, {Robert J.M.} and Nuijens, {Jan H.} and {Jan Wolbink}, Gert and Eerenberg-Belmer, {Anke J.M.} and {Van Der Vall}, Henry and John Wagstaff",

year = "1989",

month = aug,

day = "12",

doi = "https://doi.org/10.1016/S0140-6736(89)90577-1",

language = "English",

volume = "334",

pages = "395",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "8659",

}

TY - JOUR

T1 - COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2

AU - Thijs, Lambertus G.

AU - Hack, C. Erik

AU - Strack Van Schijndel, Robert J.M.

AU - Nuijens, Jan H.

AU - Jan Wolbink, Gert

AU - Eerenberg-Belmer, Anke J.M.

AU - Van Der Vall, Henry

AU - Wagstaff, John

PY - 1989/8/12

Y1 - 1989/8/12

UR - http://www.scopus.com/inward/record.url?scp=0024375136&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S0140-6736(89)90577-1

DO - https://doi.org/10.1016/S0140-6736(89)90577-1

M3 - Comment/Letter to the editor

C2 - 2569587

SN - 0140-6736

VL - 334

SP - 395

JO - The Lancet

JF - The Lancet

IS - 8659

ER -

COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2

Access to Document

Other files and links

Cite this